{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:16:05Z","timestamp":1760955365218},"reference-count":21,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.jvir.2012.06.028","type":"journal-article","created":{"date-parts":[[2012,8,24]],"date-time":"2012-08-24T01:30:45Z","timestamp":1345771845000},"page":"1278-1285","source":"Crossref","is-referenced-by-count":15,"title":["Phase I\/II Multicenter Study of Transarterial Chemoembolization with a Cisplatin Fine Powder and Porous Gelatin Particles for Unresectable Hepatocellular Carcinoma: Japan Interventional Radiology in Oncology Study Group Study 0401"],"prefix":"10.1016","volume":"23","author":[{"given":"Keigo","family":"Osuga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Anai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Aramaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanobu","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumikiyo","family":"Ganaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Seki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Sadaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Inoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Yamakado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2012.06.028_bib1","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"32","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2012.06.028_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/jhep.2003.50047","article-title":"Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival","volume":"37","author":"Llovet","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2012.06.028_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1148\/radiology.215.1.r00ap21123","article-title":"Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study","volume":"215","author":"Caturelli","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2012.06.028_bib4","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jvir.2007.07.035","article-title":"Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk","volume":"18","author":"Kothary","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2012.06.028_bib5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2214\/ajr.176.3.1760681","article-title":"Targeted transarterial oily chemoembolization for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates","volume":"176","author":"Takayasu","year":"2001","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jvir.2012.06.028_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00270-009-9711-7","article-title":"Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study","volume":"33","author":"Lammer","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2012.06.028_bib7","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s00270-010-0044-3","article-title":"Safety profile of sequential transcatheter chemoembolization with DC bead: results of 237 hepatocellular carcinoma (HCC) patients","volume":"34","author":"Malagari","year":"2011","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2012.06.028_bib8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/COC.0b013e3181df0a50","article-title":"Radioembolization for hepatocellular carcinoma","volume":"34","author":"Sangro","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jvir.2012.06.028_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1743-7563.2010.01287.x","article-title":"Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinoma","volume":"6","author":"Shao","year":"2010","journal-title":"Asia Pac J Clin Oncol"},{"key":"10.1016\/j.jvir.2012.06.028_bib10","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00270-010-9935-6","article-title":"Porous gelatin particles for uterine artery embolization: an experimental study of intra-arterial distribution, uterine necrosis, and inflammation in a porcine model","volume":"33","author":"Sone","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2012.06.028_bib11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/00000421-200012000-00006","article-title":"Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma","volume":"23","author":"Ono","year":"2000","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jvir.2012.06.028_bib12","first-page":"809","article-title":"Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma","volume":"50","author":"Maeda","year":"2003","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jvir.2012.06.028_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00270-009-9570-2","article-title":"Transarterial infusion chemotherapy using cisplatin-lipiodol suspension with or without embolization for unresectable hepatocellular carcinoma","volume":"32","author":"Kawaoka","year":"2009","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2012.06.028_bib14","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1051-0443(07)61510-3","article-title":"Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin lipiodol suspension and doxorubicin hydrochloride emulsion","volume":"12","author":"Kamada","year":"2001","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2012.06.028_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s11604-010-0436-y","article-title":"Prospective comparison of transcatheter arterial chemoembolization with lipiodol-epirubicin and lipiodol-cisplatin for treatment of recurrent hepatocellular carcinoma","volume":"28","author":"Sahara","year":"2010","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.jvir.2012.06.028_bib16","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1872-034X.2008.00338.x","article-title":"Phase II study of hepatic arterial infusion of a new-powder formulation of cisplatin for advanced hepatocellular carcinoma","volume":"38","author":"Yoshikawa","year":"2008","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jvir.2012.06.028_bib17","first-page":"202","article-title":"Suitable blending method of lipiodol-cisplatin in transcatheter arterial embolization for hepatocellular carcinoma: evaluation of sustained release and accumulation nature","volume":"55","author":"Takaki","year":"2008","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jvir.2012.06.028_bib18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00004836-200105000-00013","article-title":"Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma","volume":"32","author":"Kim","year":"2001","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jvir.2012.06.028_bib19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/j.gastro.2006.05.021","article-title":"Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients","volume":"131","author":"Takayasu","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jvir.2012.06.028_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00280-009-1034-5","article-title":"Phase I\/II study of the lipiodolization using DDP-H (CDDP powder; IA-call) in patients with unresectable hepatocellular carcinoma","volume":"65","author":"Yamashita","year":"2010","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jvir.2012.06.028_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1872-034X.2009.00606.x","article-title":"Phase I\/II study of a fine-powder formulation of cisplatin for transcatheter arterial chemoembolization in hepatocellular carcinoma","volume":"40","author":"Moriguchi","year":"2010","journal-title":"Hepatol Res"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044312006896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044312006896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T03:27:29Z","timestamp":1542770849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044312006896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1051044312006896"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2012.06.028","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}